The potential of probiotic supplements to reduce the incidence and duration of flu-like respiratory tract infections in the US could translate into over $1 billion of costs savings, according to a new economic modeling study.
A.I. and its promise for ingredient innovation
Suppliers
Fish oil and resistance training may combat sarcopenia: Study
Research
Muscle in on the market: How to build the best protein bar
Markets
Omega-3 and pre-term births: Why targeted supplementation could be critical – major new Australian trial
Research
